 success foscarnet therapi cytomegaloviru retin aid patient hemodialysi rational empir dose plasma level monitor foscarnet investig antivir agent treatment cytomegaloviru cmv retin aid patient avail aid patient renal insuffici major side effect nephrotox report efficaci safeti requir foscarnet hemodialysis-depend patient cmv retin foscarnet week initi dosag mg/kg dialysi session plasma concentr monitor weekli dosag peak plasma level rang microm laboratori abnorm preexist anemia serum calcium phosphoru ioniz calcium therapi foscarnet use altern treatment cmv retin hemodialysis-depend aid patient